Put companies on watchlist
QIAGEN N.V.
ISIN: NL0015002CX3
WKN: A40ZZU
Curious about what AI knows about Qiagen NV? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

QIAGEN N.V. · ISIN: NL0015002CX3 · EQS - adhoc news (2 News)
Country: Netherlands · Primary market: Netherlands · EQS NID: 2132288
07 May 2025 02:35PM

QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting


EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Dividend
QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting

07-May-2025 / 14:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting

Venlo, the Netherlands, May 7, 2025 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that its Supervisory Board will propose the initiation of an annual cash dividend under an amended dividend policy to QIAGEN’s shareholders at the next Annual General Meeting scheduled for June 26, 2025.

This milestone reflects QIAGEN’s strategy to introduce a new avenue to increase shareholder returns while preserving flexibility to reinvest in long-term growth.

The Supervisory Board’s decision on the amended dividend policy and initial dividend payment is subject to approval by QIAGEN’s shareholders.

The initial dividend payment would consist of $0.25 per ordinary share. This proposal represents a total payout of about $54 million. The record date is currently planned for July 2, 2025, and the payment date as July 10, 2025. All dates will be confirmed following shareholder approval.

Under the amended dividend policy, QIAGEN would have the ability to submit an annual dividend proposal to the Annual General Meeting that contemplates returning capital to shareholders while supporting sustainable growth and maintaining creditworthiness. The respective dividend proposal would consider various factors, including the amount of capital returned to shareholders, the availability of distributable profits and reserves, investments in production and R&D, working capital requirements, and potential M&A opportunities.

 

 

QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

The Netherlands

 

ISIN: NL0015002CX3

Frankfurt Stock Exchange, Regulated Market (Prime Standard)

 


Contacts QIAGEN N.V.:

 

Corporate Communications

John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com

 



End of Inside Information

07-May-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Phone: +31 7735566 - 00
Fax: +31 77 35566-58
E-mail: qiagen@qiagen.com
Internet: www.qiagen.com
ISIN: NL0015002CX3
WKN: A40ZZU
Indices: DAX, TecDAX
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, Chicago, NYSE, SIX
EQS News ID: 2132288

 
End of Announcement EQS News Service

2132288  07-May-2025 CET/CEST

Visual performance / price development - QIAGEN N.V.
Smart analysis and research tools can be found here.
MIC: XNYS

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.